Research ArticleGeneral Nuclear Medicine
Fluorine-18-Labeled Fluoroboronophenylalanine PET in Patients with Glioma
Yoshio Imahori, Satoshi Ueda, Yoshio Ohmori, Tsukasa Kusuki, Koji Ono, Ryou Fujii and Tatsuo Ido
Journal of Nuclear Medicine February 1998, 39 (2) 325-333;
Yoshio Imahori
Satoshi Ueda
Yoshio Ohmori
Tsukasa Kusuki
Koji Ono
Ryou Fujii
This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Journal of Nuclear Medicine
Vol. 39, Issue 2
February 1, 1998
Fluorine-18-Labeled Fluoroboronophenylalanine PET in Patients with Glioma
Yoshio Imahori, Satoshi Ueda, Yoshio Ohmori, Tsukasa Kusuki, Koji Ono, Ryou Fujii, Tatsuo Ido
Journal of Nuclear Medicine Feb 1998, 39 (2) 325-333;
Jump to section
Related Articles
- No related articles found.
Cited By...
- The Clinical Potential of FBPA-PET/CT Imaging for Colorectal Cancer and its Liver Metastases Expressing LAT1
- 11Boron Delivery Agents for Boron Proton-capture Enhanced Proton Therapy
- Treatment results of boron neutron capture therapy using intra-arterial administration of boron compounds for recurrent head and neck cancer
- Evaluation of Pharmacokinetics of 4-Borono-2-18F-Fluoro-L-Phenylalanine for Boron Neutron Capture Therapy in a Glioma-Bearing Rat Model with Hyperosmolar Blood-Brain Barrier Disruption
- Boron Neutron Capture Therapy of Cancer: Current Status and Future Prospects
- Evaluation of 4-Borono-2-18F-Fluoro-L-Phenylalanine-Fructose as a Probe for Boron Neutron Capture Therapy in a Glioma-Bearing Rat Model
- Prognostic and Therapeutic Indicator of Fluoroboronophenylalanine Positron Emission Tomography in Patients with Gliomas
- Imaging of Fluorine and Boron from Fluorinated Boronophenylalanine in the Same Cell at Organelle Resolution by Correlative Ion Microscopy and Confocal Laser Scanning Microscopy